What investment strategy does Oscar & Paul (Beiersdorf Venture Capital) focus on?

Oscar & Paul (Beiersdorf Venture Capital) focuses on VC strategies in the private equity space.

How many portfolio companies does Oscar & Paul (Beiersdorf Venture Capital) have?

Oscar & Paul (Beiersdorf Venture Capital) has 12 active portfolio companies and 3 completed exits and 2 funds tracked on GP Intel.

Where is Oscar & Paul (Beiersdorf Venture Capital) headquartered?

Oscar & Paul (Beiersdorf Venture Capital) is headquartered in Hamburg, Germany.

What is Oscar & Paul (Beiersdorf Venture Capital)'s assets under management?

Oscar & Paul (Beiersdorf Venture Capital) manages approximately €150M in assets under management.

When was Oscar & Paul (Beiersdorf Venture Capital) founded?

Oscar & Paul (Beiersdorf Venture Capital) was founded in 2020.

What sectors does Oscar & Paul (Beiersdorf Venture Capital) invest in?

Oscar & Paul (Beiersdorf Venture Capital) invests across Healthcare, Consumer, Energy, TMT.

What are Oscar & Paul (Beiersdorf Venture Capital)'s recent exits?

Recent realized exits by Oscar & Paul (Beiersdorf Venture Capital) include: S-Biomedic (2022) to Beiersdorf AG.

Home/GPs/Oscar & Paul (Beiersdorf Venture Capital)

DetailCard

Oscar & Paul (Beiersdorf Venture Capital)

Hamburg, Germany·Founded 2020·

Venture Capital

·vc.beiersdorf.com

Oscar & Paul is the corporate venture capital arm of Hamburg-based skin care group Beiersdorf AG (NIVEA, Eucerin, La Prairie). Launched in 2020 with an initial EUR 50m fund, it takes minority stakes (typically up to 20%, initial tickets EUR 0.5-5m) in early- to growth-stage startups at the intersection of skin care across life science and biotech, sustainability, AI and digital health, mainly in Europe, North America and APAC. It has backed more than 15 companies since 2020 and realized exits including the full acquisition of S-Biomedic and the NYSE IPO of Evommune. In March 2026 Beiersdorf doubled the programme with a new EUR 100m Skin Care Innovation Fund.

AUM

€150M

Funds

vintages 2020–2026

Portfolio

Exits

Oscar & Paul (Beiersdorf Venture Capital) is a Hamburg venture capital firm with €150M AUM, 12 active companies and 3 exits.

SectorsHealthcare Consumer Energy TMT

Key takeaways

·3 exits in the last 5 years · consistent DPI cadence.
·Average hold across 3 realized deals: 3 years.
·Top sector focus: Biotech (53% of portfolio).
·Fund cadence: ~6Y between vintages · last raise 2026.

Sector breakdown

15 companies

Biotech

8 · 53%

ClimateTech

2 · 13%

Consumer

2 · 13%

HealthTech

1 · 7%

Industrials

1 · 7%

Deep Tech

1 · 7%

Geography breakdown

9 geographies

5 · 33%

3 · 20%

France

1 · 7%

Switzerland

1 · 7%

Germany

1 · 7%

South Korea

1 · 7%

Sweden

1 · 7%

Netherlands

1 · 7%

Key facts

HQHamburg, Germany

Founded2020

Employees6+

Websitevc.beiersdorf.com

Recent exits

Oscar & Paul (Beiersdorf Venture Capital) took Evommune public in 2025 after 1 year.

Oscar & Paul (Beiersdorf Venture Capital) exited LYCL in 2024 after 5 years.

Oscar & Paul (Beiersdorf Venture Capital) sold S-Biomedic to Beiersdorf AG in 2022 after 4 years.

Coverage notes

2 funds tracked, 15 portfolio companies (12 active · 3 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Oscar & Paul (Beiersdorf Venture Capital) has raised, with its portfolio companies. Hand-checked from public filings.

2 funds

Fund

Strategy

Vintage

Size

Assets

Exits

Skin Care Innovation Fund

VC2026€100M0 assets

2026 · 0yr

€100M

–

No portfolio companies tracked yet.

Oscar & Paul Venture Capital Fund I

VC2020€50M12 assets3 exits

2020 · 6yr

€50M

Unrealized

12 held

Company	Entry
Cellvie Biotech · US	2025
DeepLife Biotech · France	2024
DePoly ClimateTech · Switzerland	2023
Dermanostic HealthTech · Germany	2022
Macro Biologics Biotech · US	2024
Melt&Marble Biotech · Sweden	2025
ReVentas ClimateTech · UK	2025
Routinely Consumer · Netherlands	2021
Rubedo Life Sciences Biotech · US	2024
Salvalco Industrials · UK	2020
Turbine Deep Tech · UK	2026
Vincere Biosciences Biotech · US	2025

Realized

3 exits

Company	Entry	Exit	Type	Buyer	MOIC
Evommune Biotech · US	2024	2025	IPO	–	–
LYCL Consumer · South Korea	2019	2024	Secondary	–	–
S-Biomedic Biotech · Belgium	2018	2022	Trade Sale	Beiersdorf AG	–

Frequently asked questions

What investment strategy does Oscar & Paul (Beiersdorf Venture Capital) focus on?: Oscar & Paul (Beiersdorf Venture Capital) focuses on VC strategies in the private equity space.
How many portfolio companies does Oscar & Paul (Beiersdorf Venture Capital) have?: Oscar & Paul (Beiersdorf Venture Capital) has 12 active portfolio companies and 3 completed exits and 2 funds tracked on GP Intel.
Where is Oscar & Paul (Beiersdorf Venture Capital) headquartered?: Oscar & Paul (Beiersdorf Venture Capital) is headquartered in Hamburg, Germany.
What is Oscar & Paul (Beiersdorf Venture Capital)'s assets under management?: Oscar & Paul (Beiersdorf Venture Capital) manages approximately €150M in assets under management.
When was Oscar & Paul (Beiersdorf Venture Capital) founded?: Oscar & Paul (Beiersdorf Venture Capital) was founded in 2020.
What sectors does Oscar & Paul (Beiersdorf Venture Capital) invest in?: Oscar & Paul (Beiersdorf Venture Capital) invests across Healthcare, Consumer, Energy, TMT.
What are Oscar & Paul (Beiersdorf Venture Capital)'s recent exits?: Recent realized exits by Oscar & Paul (Beiersdorf Venture Capital) include: S-Biomedic (2022) to Beiersdorf AG.